This month, global coronavirus cases surpassed 100 million, according to data compiled by Johns Hopkins University. Although vaccines are providing many countries with hope for a return to a ‘new normal’, there is an increasing acceptance that the way out is not as simple as might have been thought and hoped.
With a number of variants emerging, it is not yet clear whether and how the approach to vaccination will have to be adapted to successfully fight the pandemic and what this means for global distribution of vaccines.
Against this backdrop, Professor David Heymann and Emma Ross return for a new series of COVID-19 briefings aimed at understanding the science and exploring how governments and societies can sustain the response. They will be joined by Professor David Salisbury, who will help us understand where we stand with vaccines and what we can expect in coming months and years.
How concerned should we be about the threats that new variants discovered around the world pose? How effective will vaccines be against them? What challenges will scientists face in developing new vaccines to cope with these variants? To what extent can other tools, such as therapeutics and the strategic use of diagnostic testing, help combat the virus? And how and when can lockdowns end?
And what would you, the audience, like to better understand about the pandemic? At this event, we will be asking the audience to tell us what topics they would like us to unpack in the coming months.
As with all Chatham House events, audience questions drive the conversation. Register now to share, debate and develop ideas on this critical international issue.
This event series is open to the public. Members of the public may register here. Chatham House members are encouraged to register via their membership dashboard, as usual.